An investigation into the possible effect of thyroid stimulating immunoglobulin G on lipogenesis by adipocytes led to the discovery that all human IgGs exerted an insulin-like stimulatory effect on lipogenesis by rat adipocytes in vitro. Highly purified polyclonal IgGs prepared from normal subjects had stimulatory potencies similar to those of monoclonal IgGs obtained from patients with IgG myeloma. However, whole sera from myeloma patients with elevated IgG concentrations had a significantly higher stimulatory effect on adipocyte lipogenesis than control sera. These observations provide the first evidence that human IgG has an insulin-like metabolic effect, and that this effect is probably exerted by a nonspecific nonvariable portion of the IgG molecule. IgG may thus contribute to the non-suppressible insulin-like activity in the serum. DIABETES 30:1068-1071, December 1981. W e have recently shown that thyrotropin (TSH) stimulates lipogenesis by rat adipocytes. in vitro 1 but at much greater concentrations than insulin. We then examined the possibility that thyroid-stimulating antibodies (TSAb) might exert a similar stimulatory effect upon adipocytes. During the course of these investigations, it became clear that all immunoglobulin G (IgG) fractions-those obtained from sera with high titers of TSAb and those from controls-were able to stimulate adipocyte lipogenesis.
W e have recently shown that thyrotropin (TSH) stimulates lipogenesis by rat adipocytes. in vitro 1 but at much greater concentrations than insulin. We then examined the possibility that thyroid-stimulating antibodies (TSAb) might exert a similar stimulatory effect upon adipocytes. During the course of these investigations, it became clear that all immunoglobulin G (IgG) fractions-those obtained from sera with high titers of TSAb and those from controls-were able to stimulate adipocyte lipogenesis.
This article describes these experiments, which constitute the first evidence that normal human IgG may have a metabolic effect.
MATERIALS
Analytic grade sodium chloride, potassium chloride, calcium chloride, sodium dihydrogen phosphate, disodium hy-drogen phosphate, and glucose were obtained from British Drug House. Collagenase was purchased from Worthington Laboratories. Human serum albumin (crystallized) was obtained from Curewell, India. Monocomponent Actrapid porcine insulin (Novo, Copenhagen) was used in all experiments requiring insulin.
•y-Chain specific anti-IgG antiserum was obtained from Dako. Epididymal fat pads were obtained from cesarian-delivered male Sprague-Dawley rats weighing between 120 and 150 g and kept on an ad libitum diet (Grain Harvesters, Brand 41B).
The composition of Krebs-Ringer bicarbonate buffer (KRB) (pH 7.4) used in our experiments was as follows: NaCI, 121 mmol; KCI, 4.8 mmol; KH 2 PO 4 ,1.2 mmol; MgSO 4 , 1.2 mmol; NaHCO 3 , 25 mmol; and CaCI 2 , 1.3 mmol.
NORMAL SUBJECTS, PATIENTS, AND SERA
Blood samples were obtained from six normal subjects and four patients with untreated IgG myeloma. Samples were allowed to clot; serum was removed following centrifugation. In most cases, the serum was applied directly to protein Asepharose CL-4B columns for the separation of IgG. Some samples were kept at 4°C overnight before IgG separation was carried out. Myeloma proteins were indentified by immunofixation. Table 1 shows the immunoglobulin content of the four sera from myeloma patients and the four normal sera included in this study.
METHODS
Preparation of IgG. IgG fractions were prepared from six control sera and four sera from patients with an IgG myeloma. IgG was prepared by chromatography over protein Asepharose CL-4B columns: 3 IgG thus prepared was dialyzed against physiologic saline before its use.
Concentration of IgG, IgM, and IgA in IgG and serum samples was measured using laser nephelometry in a Beckman Immunochemistry Analyzer (Beckman Instruments, Inc., Fullerton, California). All IgG samples used in our experiments had less than 1% of IgM or IgA. The purity of IgG preparations was further confirmed by polyacrylamide gel electrophoresis, which showed these preparations to contain a single protein band (see Figure 1) . Insulin bioassay. Adipocyte suspensions from rat epididymal fat pads were prepared by the method of Rodbell, 4 which utilizes collagenase digestion in KRB (pH 7.4) in a shaking water bath at 37°C for 2 h. Adipocytes were resusp'ended in KRBwith[3-3 H]-glucose (0.2 fiC\ per vial, overall final glucose concentration = 0.55 mmol) for 2 h at 37°C under an atmosphere of 5% CO 2 :95% O 2 in a shaking water bath. Each incubation tube contained 4 x 10 4 adipocytes/ml. The reaction was stopped at 2 h by the addition of a toluene-based scintillant followed by vigorous shaking. This procedure lysesthe adipocytes and extracts lipids into the toluene phase, which by this stage contain the [3- 3 H]-glucose incorporated into triglycerides. Radioactivity in the lipid-toluene phase was measured as described by Moody et al., 5 using a Phillips PW 4540 liquid scintillation counter. This system works as a sensitive bioassay for insulin, giving a dose-response curve between 2.5 and 25 /nil/ml, as described by us in a previous communication. Based on the bioassay method described above, adipocyte suspensions were incubated with serial concentrations of human IgG (10-200 /xg/L), both from myeloma patients and from controls.
Sera of the four patients with myeloma and the four controls were also assayed for their insulin-like stimulatory activity in the assay system described above. Neutralization of IgG. Three IgG fractions were incubated with an excess of IgG antiserum (at least 3 ml of anti-IgG antiserum was used for every 2.8 mg of IgG) overnight at 4°C. These incubates were assayed along with the respective IgG samples and the commercial anti-IgG antisera on the same morning. Immunoglobulin from lymphocyte cultures. Blood was obtained from normal subjects and lymphocytes were separated by the method of Boyum.
7 Lymphocyte cultures were set up in a modified Marbrook system. 8 Supernatants were obtained from these cultures at 15 days and pooled.
Immunoglobulin G was prepared from pooled supernatants as described above by chromatography over protein A-sepharose columns. A fraction of the IgG thus prepared was incubated with -y-chain specific anti-IgG antiserum overnight. IgG from lymphocyte cultures and that preincubated with anti-IgG antiserum were assayed on the same morning.
CALCULATIONS
Six tubes containing adipocyte suspensions were used to test each concentration of insulin, IgG fractions, or serum samples. The mean of lipid extractable radioactive counts was used as an index of lipogenesis. All results are expressed as percent stimulation over basal metabolism, the latter being the mean counts per minute (cpm) incorporated into the toluene-soluble lipid phase by adipocytes incubated without insulin or any other test material described above. The significance of the difference between two observations was calculated by a Student's t test.
RESULTS
All IgG samples induced a significant insulin-like stimulation of lipogenesis by adipocytes. The threshold concentration for this effect of IgG was 10-15 /u.g/ml, and the response increased progressively up to concentrations of 200 (xg/m\ (Figure 2 ). There was no difference in the magnitude of stimulation between IgG fractions obtained from patients with IgG myeloma and those from controls.
However, when neat sera from myeloma patients and controls were used, there was significantly greater stimulation with the former (Figure 3) .
The three IgG preparations preincubated with y-chain specific anti-IgG antiserum lost their insulin-like stimulatory activity completely (Table 2) .
IgG harvested from human lymphocyte cultures produced an insulin-like stimulation of adipocyte lipogenesis of a magnitude similar to that induced by IgG from sera. Preincubation of IgG from lymphocyte cultures with y-chain specific anti-IgG antiserum neutralized its stimulatory effect (Table 2) .
DISCUSSION
Our data show clearly that human IgG fractions, obtained from sera of normal subjects and patients with IgG myeloma, exert a stimulatory effect upon lipogenesis in rat adipocytes. Preincubation of IgG samples with y-chain specific IgG antisera neutralized this stimulatory effect of IgG. Furthermore, IgG harvested from lymphocyte cultures produced an effect identical to that induced by IgG samples obtained from sera at similar concentrations. This effect was neutralized by y-chain specific anti-IgG antiserum as well. Our data constitute the first evidence that normal IgG may have a potent metabolic effect. It is of interest that sera from patients with IgG myeloma (which had higher IgG concentrations than controls) were significantly more stimulatory in our system than those for normal subjects; however, purified myeloma IgGs had a stimulatory potency similar to that of normal IgGs. These facts suggest that the portion of the IgG molecule responsible for this effect is in the nonvariable region, probably in the Fc fraction. It is unlikely that four different monoclonal IgGs would have potencies identical to polyclonal IgGs if the variable Fab portion of the molecule was responsible for this effect.
The significance of IgG-stimulated lipogenesis in technical and biological terms is difficult to establish at this moment. In technical terms, IgG must contribute to nonsuppressible insulin-like activity, and this must be taken into account while investigating serum factors that possess insulin-like activity (NSILA). Thus IgG would have to be included in the list of plasma components, including zinc, 6 that have been shown to be responsible for NSILA. In biological terms, the possibility that it may also have somatomedin-like activity in other biological systems must be considered.
Another important fact which requires exploration is the marked potency of IgG in this system. It is effective at concentrations less than 1% of those found in the plasma, and yet whole serum/plasma is not markedly stimulatory in the fat cell system. This paradox would indicate that there probably exists a concomitant inhibitor in the serum/plasma that neutralizes the stimulatory effect of IgG. Our initial experiments confirm this. These data are to be presented separately elsewhere. Each value shows percent stimulation over basal and represents the mean ± SEM of 18 (3 x 6) observations derived from three complete experiments.
In terms of pathophysiology, our observations suggest that selective deposition of IgG at inflammatory sites may be the setting where the metabolic effects of IgG become relevant. It is possible that cells other than adipocytes, especially those involved in inflammatory responses, are stimulated by IgG: for example, IgGs may stimulate phagocytes and other inflammatory cells into greater metabolic activity. This area requires further investigation.
We are at present investigating the effects of IgG on homologous systems, i.e., human IgG on human adipocytes and rat IgG on rat adipocytes to establish their true biological role.
The data presented here may appear to contradict the observations of Kahn et al., who demonstrated a paradoxical stimulatory effect in vitro of IgG obtained from the sera of patients with insulin resistance due to insulin receptor antibody. 9 However, these workers demonstrated that the Fab fractions obtained from these IgG fractions were responsible for this effect. This is unlikely to be the case with normal IgG in view of the preceding discussion, which indicates (1) a nonspecific basis for this effect of human IgG, and (2) the fact that Fc fractions may be responsible. Furthermore, sera from patients with insulin receptor antibody were in themselves markedly stimulatory to adipocytes in vitro. Thus the stimulatory effect of IgGs from these patients and from normal subjects would appear to be qualitatively different. Whether a proportion of the stimulatory effect of IgGs from patients with insulin receptor antibody is due to normal IgG is a question that needs further elucidation. This problem would have been helped considerably if Kahn et al. 9 had compared the potency of normal IgG with that obtained from sera from patients with insulin receptor antibody. Unfortunately, their article makes no mention of the stimulatory potency of normal IgG on the fat cell system.
